CryoTherapeutics partners with SpectraWAVE and CRF to Launch ICECAP: A First-of-its-Kind Clinical Study Targeting Non-Obstructive High-Risk Coronary Plaques with Cryotherapy and Advanced Intravascular Imaging

Contributed by: Business Wire

Logo

Tags

Cardiology

Radiology

Health

Artificial Intelligence

Medical Devices

Health Technology

Technology

Clinical Trials

SpectraWAVE

More Like This

PR Newswire associated0

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for vessels of the peripheral arterial and venous systems

PR Newswire associated0

Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market

VISABL-AFL Procedure at ICPS (Photo: Business Wire)

Imricor’s VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris

Imricor’s NorthStar® Mapping System

First in Human Ischemic VT Ablation Successfully Performed in iCMR

PR Newswire associated0

New Published Study Demonstrates Safety and Feasibility of Filterlex Medical's CAPTIS® Device in Providing Embolic Protection During TAVR

PR Newswire associated0

Pie Medical Imaging announces enrollment completion of the FASTIII clinical trial

PR Newswire associated0

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience